E&G Advisors’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $491K | Hold |
979
| – | – | 0.09% | 147 |
|
|
2026
Q1 | $481K | Buy |
979
+10
| +1% | +$5.43K | 0.11% | 139 |
|
|
2025
Q4 | $561K | Hold |
969
| – | – | 0.13% | 121 |
|
|
2025
Q3 | $470K | Hold |
969
| – | – | 0.11% | 135 |
|
|
2025
Q2 | $393K | Hold |
969
| – | – | 0.1% | 141 |
|
|
2025
Q1 | $482K | Hold |
969
| – | – | 0.14% | 126 |
|
|
2024
Q4 | $504K | Hold |
969
| – | – | 0.14% | 123 |
|
|
2024
Q3 | $599K | Hold |
969
| – | – | 0.17% | 117 |
|
|
2024
Q2 | $536K | Hold |
969
| – | – | 0.16% | 117 |
|
|
2024
Q1 | $563K | Buy |
969
+14
| +1% | +$7.86K | 0.18% | 109 |
|
|
2023
Q4 | $507K | Sell |
955
-30
| -3% | -$14.5K | 0.18% | 110 |
|
|
2023
Q3 | $499K | Sell |
985
-50
| -5% | -$26.6K | 0.18% | 112 |
|
|
2023
Q2 | $540K | Hold |
1,035
| – | – | 0.19% | 106 |
|
|
2023
Q1 | $597K | Sell |
1,035
-110
| -10% | -$62K | 0.22% | 97 |
|
|
2022
Q4 | $631K | Hold |
1,145
| – | – | 0.24% | 97 |
|
|
2022
Q3 | $581K | Sell |
1,145
-100
| -8% | -$56K | 0.21% | 93 |
|
|
2022
Q2 | $676K | Buy |
1,245
+100
| +9% | +$55K | 0.23% | 92 |
|
|
2022
Q1 | $676K | Sell |
1,145
-100
| -8% | -$57.4K | 0.18% | 108 |
|
|
2021
Q4 | $831K | Hold |
1,245
| – | – | 0.21% | 92 |
|
|
2021
Q3 | $711K | Buy |
+1,245
| New | +$683K | 0.19% | 100 |
|
|
2021
Q2 | – | Sell |
-1,095
| Closed | -$517K | – | 110 |
|
|
2021
Q1 | $500K | Buy |
1,095
+150
| +16% | +$71.6K | 0.15% | 123 |
|
|
2020
Q4 | $440K | Hold |
945
| – | – | 0.14% | 127 |
|
|
2020
Q3 | $417K | Hold |
945
| – | – | 0.14% | 116 |
|
|
2020
Q2 | $342K | Hold |
945
| – | – | 0.13% | 127 |
|
|
2020
Q1 | $268K | Hold |
945
| – | – | 0.13% | 136 |
|
|
2019
Q4 | $307K | Hold |
945
| – | – | 0.11% | 163 |
|
|
2019
Q3 | $275K | Hold |
945
| – | – | 0.11% | 161 |
|
|
2019
Q2 | $278K | Hold |
945
| – | – | 0.12% | 157 |
|
|
2019
Q1 | $259K | Sell |
945
-53
| -5% | -$13.2K | 0.11% | 163 |
|
|
2018
Q4 | $223K | Hold |
998
| – | – | 0.1% | 173 |
|
|
2018
Q3 | $244K | Buy |
+998
| New | +$230K | 0.09% | 184 |
|
|
2018
Q1 | – | Sell |
-1,245
| Closed | -$236K | – | 214 |
|
|
2017
Q4 | $236K | Sell |
1,245
-500
| -29% | -$95.8K | 0.1% | 185 |
|
|
2017
Q3 | $330K | Sell |
1,745
-600
| -26% | -$109K | 0.15% | 128 |
|
|
2017
Q2 | $409K | Sell |
2,345
-600
| -20% | -$101K | 0.2% | 106 |
|
|
2017
Q1 | $452K | Hold |
2,945
| – | – | 0.23% | 95 |
|
|
2016
Q4 | $416K | Sell |
2,945
-100
| -3% | -$14.7K | 0.25% | 86 |
|
|
2016
Q3 | $484K | Buy |
3,045
+900
| +42% | +$139K | 0.28% | 75 |
|
|
2016
Q2 | $317K | Buy |
2,145
+45
| +2% | +$6.64K | 0.19% | 85 |
|
|
2016
Q1 | $297K | Hold |
2,100
| – | – | 0.19% | 79 |
|
|
2015
Q4 | $298K | Sell |
2,100
-100
| -5% | -$13.3K | 0.18% | 79 |
|
|
2015
Q3 | $269K | Buy |
+2,200
| New | +$287K | 0.17% | 78 |
|
Other funds holding TMO
RG
LT
ATO
CF
E&G Advisors's TMO Position: Q2 2026 in Review
E&G Advisors held its Thermo Fisher Scientific (TMO) position steady in Q2 2026 at 979 shares worth $491K. The position accounts for 0.09% of the portfolio, ranked #147.
E&G Advisors first reported a position in TMO in Q3 2015 and has held it in 41 quarters since. The position peaked at $831K in Q4 2021. 708 funds tracked by Wall St. Rank hold TMO as of Q2 2026.
- E&G Advisors held 979 shares of Thermo Fisher Scientific worth $491K as of Q2 2026.
- E&G Advisors left its Thermo Fisher Scientific share count unchanged in Q2 2026.
- Thermo Fisher Scientific made up 0.09% of E&G Advisors's portfolio in Q2 2026, its #147 holding.
- E&G Advisors first reported a position in Thermo Fisher Scientific in Q3 2015 and has held it in 41 quarters since.
- E&G Advisors's Thermo Fisher Scientific position peaked at $831K in Q4 2021.
- 708 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.
Based on E&G Advisors's 13F filing for Q2 2026, filed 23 Jul 2026.